Active site remodeling in tumor-relevant IDH1 mutants drive distinct kinetic features and possible resistance mechanisms
Mealka, M., Sohl, C.D., Huxford, T.To be published.
Experimental Data Snapshot
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
Isocitrate dehydrogenase [NADP] cytoplasmic | 430 | Homo sapiens | Mutation(s): 1  Gene Names: IDH1, PICD EC: 1.1.1.42 | ||
UniProt & NIH Common Fund Data Resources | |||||
Find proteins for O75874 (Homo sapiens) Explore O75874  Go to UniProtKB:  O75874 | |||||
PHAROS:  O75874 GTEx:  ENSG00000138413  | |||||
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
UniProt Group | O75874 | ||||
Sequence AnnotationsExpand | |||||
|
Ligands 6 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
EE1 (Subject of Investigation/LOI) Query on EE1 | E [auth A], M [auth C] | (3~{S})-3-[(4~{S})-3-aminocarbonyl-1-[(2~{R},3~{R},4~{S},5~{R})-5-[[[[(2~{R},3~{R},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3-oxidanyl-4-phosphonooxy-oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxymethyl]-3,4-bis(oxidanyl)oxolan-2-yl]-4~{H}-pyridin-4-yl]-2-oxidanylidene-pentanedioic acid C26 H34 N7 O22 P3 WSGZIHXYYXDDDT-PJNAXEGASA-N | |||
NDP (Subject of Investigation/LOI) Query on NDP | H [auth B], O [auth D] | NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE C21 H30 N7 O17 P3 ACFIXJIJDZMPPO-NNYOXOHSSA-N | |||
AKG (Subject of Investigation/LOI) Query on AKG | J [auth B] | 2-OXOGLUTARIC ACID C5 H6 O5 KPGXRSRHYNQIFN-UHFFFAOYSA-N | |||
GOL Query on GOL | P [auth D] | GLYCEROL C3 H8 O3 PEDCQBHIVMGVHV-UHFFFAOYSA-N | |||
NO3 Query on NO3 | F [auth A], I [auth B], L [auth C] | NITRATE ION N O3 NHNBFGGVMKEFGY-UHFFFAOYSA-N | |||
CA Query on CA | G [auth A], K [auth B], N [auth C], Q [auth D] | CALCIUM ION Ca BHPQYMZQTOCNFJ-UHFFFAOYSA-N |
Length ( Å ) | Angle ( ˚ ) |
---|---|
a = 83.821 | α = 90 |
b = 104.86 | β = 98.19 |
c = 107.711 | γ = 90 |
Software Name | Purpose |
---|---|
PHENIX | refinement |
XDS | data reduction |
XDS | data scaling |
PHENIX | phasing |
Funding Organization | Location | Grant Number |
---|---|---|
American Cancer Society | United States | RSG-19-075-01-TBE |
National Institutes of Health/National Cancer Institute (NIH/NCI) | United States | R35 GM137773 |